Kawasan Industri Jababeka Tbk (KIJA)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 115.00 |
|---|---|
| 52-week range | 103.26 – 357.98 |
| Return, 1 month / 3 months | −36.1% / −15.4% |
| Return, 1 year / 3 years | −35.0% / −20.7% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 80.7% |
| Worst drawdown (1 year) | -68.6% |
| Average daily value traded | 76,488.46M IDR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kawasan Industri Jababeka is an Indonesian property and industrial estate developer based in Cikarang, West Java. It develops and manages industrial parks and integrated townships, selling industrial land and providing estate infrastructure and utilities to manufacturing tenants and other businesses. The company also develops residential and commercial property within its townships, serving companies and households in the surrounding industrial region.
Kawasan Industri Jababeka Tbk trades under the code KIJA on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kawasan Industri Jababeka Tbk (KIJA) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 115.00 on 19 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 579 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.0% and over the last three months it fell 15.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -33.8% | ||
| From 52-week high | -67.0% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.4% | ||
| 6-month return | -36.8% | ||
| 12-month return, skipping the last month | 1.7% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 80.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -68.6% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 76,488.46M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −19.6% |
|---|---|
| 1 month | −36.1% |
| 3 months | −15.4% |
| 6 months | −36.8% |
| 1 year | −35.0% |
| 3 years | −20.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 172.26 / 173.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | IDR 2.0349 |
| 7 Jul 2025 | IDR 1.7669 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.